Cas:666727-31-7 2-chloro-3-iodophenol manufacturer & supplier

We serve Chemical Name:2-chloro-3-iodophenol CAS:666727-31-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-chloro-3-iodophenol

Chemical Name:2-chloro-3-iodophenol
CAS.NO:666727-31-7
Synonyms:Phenol,2-chloro-3-iodo
Molecular Formula:C6H4ClIO
Molecular Weight:254.45300
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:285.3ºC at 760 mmHg
Density:2.087g/cm3
Index of Refraction:1.677
PSA:20.23000
Exact Mass:253.90000
LogP:2.65020

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Phenol,2-chloro-3-iodo chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Phenol,2-chloro-3-iodo physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Phenol,2-chloro-3-iodo Use and application,Phenol,2-chloro-3-iodo technical grade,usp/ep/jp grade.


Related News: The agency said it was not yet ready to authorize Emergent BioSolutions Inc’s (EBS.N) plant for manufacturing the J&J vaccine. 2-chloro-3-iodophenol manufacturer The FDA approval allows Biogen to sell its product over several years – with forecasts for potential annual sales reaching as high $10 billion to $50 billion – until the company completes a required follow-up study. 2-chloro-3-iodophenol supplier From the perspective of product structure, the varieties of these enterprises are mainly concentrated in vitamins, antipyretics and analgesics, antibiotics and corticosteroids (ie bulk drug substances). 2-chloro-3-iodophenol vendor This is particularly important in reducing overall disease burden. Moreover, this strategic decision will not only strengthen our diabetes portfolio but also help consolidate our position as the fastest-growing player in the anti-diabetes segment, Mankind Pharma Director of Marketing Sanjay Koul said in a statement. 2-chloro-3-iodophenol factory This is particularly important in reducing overall disease burden. Moreover, this strategic decision will not only strengthen our diabetes portfolio but also help consolidate our position as the fastest-growing player in the anti-diabetes segment, Mankind Pharma Director of Marketing Sanjay Koul said in a statement.